Oxidants as stimulators of signal transduction

Free Radical Biology and Medicine

Volumn 22, Issue 1-2, 1997, Pages 269-285

  Suzuki, Yuichiro Justin ^a   Forman, Henry Jay ^b   Sevanian, Alex ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Calcium; Free radical; Peroxide; Phospholipase; Phosphorylation; Second messenger; Superoxide; Transcription factor

Indexed keywords

CALCIUM; FREE RADICAL; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL GROWTH; CHEMOTAXIS; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SPECIES DIFFERENTIATION;

ANIMALIA;

EID: 0029979744     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00275-4     Document Type: Article

References (184)

1. Berridge M. J., Irvine R. F. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature. 312:1984;315-321.
2. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 308:1984;693-698.
3. Birnbaumer L., Abramowitz J., Brown A. M. Receptor-effector coupling by G proteins. Biochim. Biophys. Acta. 1031:1990;163-224.
4. Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 6:1992;2581-2590.
5. Bokoch G. M., Der C. J. Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J. 7:1993;750-759.
6. Fischer E. H., Krebs E. G. Relationship of structure to function of muscle phosphorylase. Fed. Proc. 25:1966;1511-1520.
7. Perlmutter R. M., Levin S. D., Appleby M. W., Anderson S. J., Alberola-Ila J. Regulation of lymphocyte function by protein phosphorylation. Annu. Rev. Immunol. 11:1993;451-499.
8. Chan A. C., Desai D. M., Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:1994;555-592.
9. Ignarro L. J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41:1991;485-490.
10. Lowenstein C. J., Snyder S. H. Nitric oxide, a novel biological messenger. Cell. 70:1992;705-707.
11. Berridge M. J. Calcium oscillations. J. Biol. Chem. 265:1990;9583-9586.
12. Roveri A., Coassin M., Maiorino M., Zamburlini A., van Amsterdam F. Th. M., Ratti E., Ursini F. Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells. Arch. Biochem. Biophys. 297:1992;265-270.
13. 2+ pumps of coronary artery. Am. J. Physiol. 255:1988;C297-C303.
14. Grover A. K., Samson S. E. Protection of Ca pump of coronary artery against inactivation by superoxide radical. Am. J. Physiol. 256:1989;C666-C673.
15. 2+-ATPase of vascular smooth muscle sarcoplasmic reticulum by reactive oxygen intermediates. Am. J. Physiol. 261:1991;H568-H574.
16. Grover A. K., Samson S. E., Fomin V. P. Peroxide inactivates calcium pump in pig coronary artery. Am. J. Physiol. 263:1992;H537-H543.
17. 2+-release from vascular smooth muscle sarcoplasmic reticulum. Am. J. Physiol. 262:1992;H114-116.
18. 2+ stores and protein synthesis in human endothelial cells. Circ. Res. 76:1995;388-395.
19. 2+-flux pathways in canine venous endothelial cells. Biochem. J. 297:1994;209-215.
20. 2 and dithiothreitol. Am. J. Physiol. 267:1994;H1010-1016.
21. 2+-release channels of skeletal sarcoplasmic reticulum vesicles reconstituted in lipid bilayers. Arch. Biochem. Biophys. 308:1994;214-221.
22. Holmberg, S. R. M.; Cumming, D.; Kusama, Y.; Hearse, D. J.; Poole-Wilson, P. A.; Shattock, M. J.; Williams, A. J. Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardiosci 2:19-15; 1991.
23. 2+ release channel from skeletal muscle sarcoplasmic reticulum. Arch. Biochem. Biophys. 292:1992;522-528.
24. 2+ exchanger in rat (Rattus norvegicus) cardiac myocytes. Bulletin. MDIBL. 35:1996;33-34.
25. Rooney T. A., Renard D. C., Sass E. J., Thomas A. P. Oscillatory cytosolic calcium waves independent of stimulated inositol 1,4,5-trisphosphate formation in hepatocytes. J. Biol. Chem. 266:1991;12272-12282.
26. Renard D. C., Seitz M. B., Thomas A. P. Oxidized glutathione causes sensitization of calcium release to inositol 1,4,5-trisphosphate in permeabilized hepatocytes. Biochem. J. 284:1992;507-512.
27. Missiaen L., Taylor C. W., Berridge M. J. Spontaneous calcium release from inositol trisphosphate-sensitve calcium stores. Nature. 352:1991;241-244.
28. 2+ store. Biochem. J. 312:1995;485-489.
29. Sweetman L. L., Zhang N. Y., Peterson H., Gopalakrishna R., Sevanian A. Effect of linoleic acid hydroperoxide on endothelial cell calcium homeostasis and phospholipid hydrolysis. Arch. Biochem. Biophys. 323:1995;97-107.
30. 2+ and membrane potential. Arch. Biochem. Biophys. 259:1987;457-465.
31. Murphy J. K., Hoyal C. R., Livingston F. R., Forman H. J. Modulation of the alveolar macrophage respiratory burst by hydroperoxides. Free Radic. Biol. Med. 18:1995;37-45.
32. Livingston F. R., Lui E. M. K., Loeb G. A., Forman H. J. Sublethal oxidant stress induces a reversible increase in intracellular calcium dependent on NAD(P)H oxidation in rat alveolar macrophages. Arch. Biochem. Biophys. 299:1992;83-91.
33. I in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J. 6:1992;919-924.
34. Wang S.-Y., Clague J. R., Langer G. A. Increase in calcium leak channel activity by metabolic inhibition or hydrogen peroxide in rat ventricular myocytes and its inhibition by polycation. J. Mol. Cell. Cardiol. 27:1995;211-222.
35. Reeves J. P., Bailey C. A., Hale C. C. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J. Biol. Chem. 261:1986;4948-4955.
36. Matsuura H., Shattock M. J. Membrane potential fluctuations and transient inward current induced by reactive oxygen intermediates in isolated rabbit ventricular cells. Circ. Res. 68:1991;319-329.
37. Jabr R. I., Cole W. C. Alterations in electrical activity and membrane currents induced by intracellular oxygen-derived free radical stress in guinea pig ventricular myocytes. Circ. Res. 72:1993;1229-1244.
38. Goldhaber J. I., Liu E. Excitation-contraction coupling in single guinea-pig ventricular myocytes exposed to hydrogen peroxide. J. Physiol. 477:1994;135-147.
39. Lederer, W. J.; Niggli, E.; Hadley, R. W. Sodium-calcium exchange in excitable cells: Fuzzy space. Science 248:283-284.
40. 2+ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. Proc. Natl. Acad. Sci. USA. 75:1978;1690-1694.
41. Sies H., Graf P., Estrela J. M. Hepatic calcium efflux during cytochrome P-450-dependent drug oxidations at the endoplasmic reticulum in intact liver. Proc. Natl. Acad. Sci. USA. 78:1981;3358-3362.
42. 2+ cycling and membrane damage during tert-butyl hydroperoxide metabolism by rat-liver mitochondria. Eur. J. Biochem. 140:1984;1-6.
43. Gunter T. E., Pfeiffer D. R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258:1990;C755-C786.
44. Lötscher H. R., Winterhalter K. H., Carafoli E., Richter C. Hydroperoxides can modulate the redox state of pyridine nucleotides and the calcium balance in rat liver mitochondria. Proc. Natl. Acad. Sci. USA. 76:1979;4340-4344.
45. 2+ efflux and membrane damage during t-butylhydroperoxide metabolism by liver mitochondria. FEBS Lett. 153:1983;289-292.
46. 2+ release from mitochondria induced by prooxidants. Free Radic. Biol. Med. 4:1988;365-375.
47. I during exposure to oxidative stress. Presented at the Annual Meeting of The Oxygen Society, Pasadena, CA; 1995.
48. Chan T. M., Chen E., Tatoyan A., Shargill N. S., Pleta M., Hochstein P. Stimulation of tyrosine-specific protein phosphorylation in the rat liver plasma membrane by oxygen radicals. Biochem. Biophys. Res. Commun. 139:1986;439-445.
49. 2 and vanadate concomitantly stimulates protein tyrosine phosphorylation and polyphosphoinositide breakdown in different cell lines. Biochemistry. 29:1990;10240-10245.
50. Hayes G. R., Lockwood D. H. Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 84:1987;8115-8119.
51. 2. J. Biol. Chem. 262:1987;8252-8256.
52. Koshio O., Akanuma Y., Kasuga M. Hydrogen peroxide stimulates tyrosine phosphorylation of the insulin receptor and its tyrosine kinase activity in intact cells. Biochem. J. 250:1988;95-101.
53. Fantus I. G., Kadota S., Deragon G., Foster B., Posner B. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry. 28:1989;8864-8871.
54. Heffetz D., Bushkin I, Dror R., Zick Y. The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 265:1990;2896-2902.
55. Yang D. C., Brown A. B., Chan T. M. Stimulation of tyrosine-specific protein phosphorylation and phosphatidylinositol phosphorylation by orthovanadate in rat liver plasma membrane. Arch. Biochem. Biophys. 274:1989;659-662.
56. Chen Y., Yang D.-C., Brown A. B., Jeng Y., Tatoyan A., Chan T. M. Activation of a membrane-associated phosphatidylinositol kinase through tyrosine-protein phosphorylation by naphthoquinones and orthovanadate. Arch. Biochem. Biophys. 283:1990;184-192.
57. Chen Y., Chan T. M. Orthovanadate and 2,3-dimethoxy-1,4 naphthoquinone augment growth factor-induced cell proliferation and c-fos gene expression in 3T3-L1 cells. Arch. Biochem. Biophys. 305:1993;9-16.
58. LCK in T cells. Oncogene. 8:1993;3133-3139.
59. FYN tyrosine kinases in human lymphocytes. Blood. 82:1993;1212-1220.
60. 2-induced T cell signal transduction. J. Biol. Chem. 269:1994;20718-20726.
61. 2+ signals. J. Biol. Chem. 268:1993;16688-16692.
62. Staal F. J. T., Anderson M. T., Staal G. E. J., Herzenberg L. A., Gitler C., Herzenberg L. A. Redox regulation of signal transduction: Tyrosine phosphorylation and calcium influx. Proc. Natl. Acad. Sci. USA. 91:1994;3619-3622.
63. Garcia-Morales P., Minami Y., Luong E., Klausner R. D., Samelson L. E. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: Studies with phenylarsine oxide. Proc. Natl. Acad. Sci. USA. 87:1990;9255-9259.
64. 2 and vanadate administration into rat livers. Mol. Cell. Endocrinol. 97:1993;9-17.
65. 2 on protein tyrosine phosphatase activity in HER14 cells. Free Radic. Biol. Med. 16:1994;399-403.
66. Fischer E. H., Charbonneau H., Tonks N. K. Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes. Science. 253:1991;401-406.
67. Larsson R., Cerutti P. Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants. Cancer Res. 49:1989;5627-5632.
68. Kass G. E. N., Duddy S. K., Orrenius S. Activation of hepatocyte protein kinase C by redox-cycling quinones. Biochem. J. 260:1989;499-507.
69. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. USA. 86:1989;6758-6762.
70. Gopalakrishna R., Anderson W. B. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys. 285:1991;382-387.
71. Nemani R., Lee E. Y. C. Reactivity of sulfhydryl groups of the catalytic subunits of rabbit skeletal muscle protein phosphatases 1 and 2A. Arch. Biochem. Biophys. 300:1993;24-29.
72. Guy G. R., Cairns J., Ng S., Tan Y. H. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J. Biol. Chem. 268:1993;2141-2148.
73. Barchowsky A., Williams M. E., Benz C. C., Chepenik K. P. Oxidant-sensitive protein phosphorylation in endothelial cells. Free Radic. Biol. Med. 16:1994;771-777.
74. 2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res. 54:1994;12-15.
75. Keyse S. M., Emslie E. A. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature. 359:1992;644-647.
76. Alessi D. R., Smythe C., Deyse S. M. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene. 8:1993;2015-2020.
77. 2 and arachidonic acid release in signal transduction. Biochem. Soc. Trans. 18:1990;503-507.
78. Shimidzu T., Wolfe L. S. Arachidonic acid and signal transduction. J. Neurol. 55:1990;1-15.
79. 2 for activation on the assembled NADPH oxidase in human neutrophils. Biochem. J. 297:1994;217-223.
80. Högberg J., Moldéus P., Arborgh B., O'Brien P. J., Orrenius S. The consequences of lipid peroxidation in isolated hepatocytes. Eur. J. Biochem. 59:1975;457-462.
81. 2 activity in liposomes composed of unsaturated phospholipids: A structural basis for enzyme activation. Biochim. Biophys. Acta. 961:1988;316-327.
82. Kornberg R. D., McConnell H. M. Inside-outside transitions of phospholipids in vesicle membranes. Biochemistry. 10:1971;1111-1120.
83. Barsukov L. I., Victorov A. V., Vasilendo I. A., Evstigneeva R. P., Bergelson L. D. Investigation of the inside-outside distribution, intermembrane exchange and transbilayer movement of phospholipids in sonicated vesicles by shift reagent NMR. Biochim. Biophys. Acta. 598:1980;153-168.
84. Coolbear K. P., Keough K. M. W. Lipid oxidation and gel to liquid-crystalline transition temperatures of synthetic polyunsaturated mixed-acid phosphatidylcholines. Biochim. Biophys. Acta. 732:1983;531-540.
85. Dezgenes N., Paiement J., Freeman K. B., Lopez N. G., Wilschut J., Papahadjopoulos D. Modulation of membrane fusion by ionotropic and thermotropic phase transitions. Biochemistry. 23:1984;3486-3494.
86. Wratten M. L., Gratton E., Van de Ven M., Sevanian A. DPH lifetime distributions in vesicles containing phospholipid hydroperoxides. Biochem. Biophys. Res. Commun. 164:1989;169-173.
87. 2 in pulmonary endothelium. Am. J. Physiol. 257:1989;L430-L437.
88. Elliott S. J., Meszaros G., Schilling W. P. Effect of oxidant stress on calcium signalling in vascular endothelial cells. Free Radic. Biol. Med. 13:1992;635-650.
89. 2. Lipids. 15:1980;534-543.
90. Beckman J. K., Borowitz S. M., Burr I. M. The role of phospholipase A activity in rat liver microsomal lipid peroxidation. J. Biol. Chem. 262:1987;1479-1484.
91. Robison T., Sevanian A., Forman H. Inhibition of arachidonic acid release by nordihydroguaiaretic acid and its antioxidant action in rat alveolar macrophages and Chinese hamster lung fibroblasts. Toxicol. Appl. Pharmacol. 105:1990;113-122.
92. 2. Biochim. Biophys. Acta. 876:1986;639-645.
93. 2 susceptibility of membranes containing hydroperoxy- vs. hydroxy-phosphatidylcholine. FASEB J. 4:1990;A764.
94. Pentland A. P., Morrison A. R., Jacobs S. C., Aruza L. L., Hebert J. S., Packer L. Tocopherol analogs suppress arachidonic acid metabolism with phospholipase inhibition. J. Biol. Chem. 267:1992;15528-15584.
95. Pacifici E. H. K., McLeod L. L., Sevanian A. Lipid hydroperoxide-induced peroxidation and turnover of endothelial cell phospholipids. Free Radic. Biol. Med. 17:1994;297-309.
96. 2+-dependent and independent hydrolysis of phosphatidylcholine in alveolar epithelial cells. Am. J. Physiol. 263:1992;L430-L438.
97. Shasby D. M., Yorek M., Shaby S. S. Exogenous oxidants initiate hydrolysis of endothelial cell inositol phospholipids. Blood. 72:1988;491-499.
98. 2 in pulmonary endothelium. Am. J. Physiol. 257:1989;L430-L437.
99. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
100. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-612.
101. 2 in pulmonary endothelium. Eur. J. Biochem. 206:1992;965-972.
102. Duane P. G., Rice K. L., Charboneau D. E., King M. B., Gilboe D. P., Niewehner D. E. Relationship of oxidant mediated cytotoxicity to phospholipid metabolism in endothelial cells. Am. J. Respir. Cell Mol. Biol. 4:1991;408-416.
103. 2 towards peroxidized phosphatidylcholine. Arch. Biochem. Biophys. 304:1993;123-132.
104. 2: Activation by substrate replenishment. Biochemistry. 30:1991;7340-7348.
105. 2: Determination of the interfacial kinetic rate constants. Biochemistry. 30:1991;7283-7297.
106. 2: Substrate specificity in vesicles. Biochemistry. 29:1991;7318-7329.
107. 2(s); Comparison of arachidonyl-selective and nonselective enzymes. FASEB J. 7:1993;339-348.
108. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268:1993;1960-1964.
109. 2 with membrane in the macrophage cell line RAW 264. J. Biol. Chem. 265:1990;5409-5413.
110. 2. J. Clin. Invest. 82:1988;168-176.
111. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043-1051.
112. Goldman R., Ferber R., Meller R., Zor U. A role for reactive oxygen species in zymosan and beta-glucan induced protein tyrosine phosphorylation and phospholipase activation in murine macrophages. Biochim. Biophys. Acta. 1222:1994;265-276.
113. 2. J. Biol. Chem. 269:1994;19480-19487.
114. 2 activation: Potentiation by vanadate. Biochem. J. 295:1993;879-888.
115. Natarajan V., Taher M. M., Roehm B., Parinandi N. L., Schmid H. H., Kiss Z., Garcia J. G. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J. Biol. Chem. 268:1993;930-937.
116. Natarajan V., Scribner W. M., Taher M. M. 4-Hydroxynonenal, a metabolite of lipid peroxidation, activates phospholipase D in vascular endothelial cells. Free Radic. Biol. Med. 15:1993;365-375.
117. Kiss Z., Anderson W. H. Hydrogen peroxide regulates phospholipase D-mediated hydrolysis of phosphatidylethanolamine and phosphatidylcholine by different mechanisms in NIH 3T3 fibroblasts. Arch. Biochem. Biophys. 311:1994;430-436.
118. Bourgoin S., Grinstein S. Peroxides of vanadate induce activation of phospholipase D in HL-60 cells. Role of tyrosine phosphorylation. J. Biol. Chem. 267:1992;11908-11916.
119. Rivera V. M., Greenberg M. E. Growth factor-induced gene expression: The ups and downs of c-fos regulation. New Biol. 2:1990;751-758.
120. 2+ mobilization and protein kinase C activation. J. Biol. Chem. 264:1989;526-530.
121. Haliday E. M., Ramesha C. S., Ringold G. TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite. EMBO J. 10:1991;109-115.
122. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49:1987;741-752.
123. Crawford D., Zbinden I., Amstad P., Cerutti P. Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells. Oncogene. 3:1988;27-32.
124. Shibanuma M., Kuroki T., Nose K. Induction of DNA replication and expression of proto-oncogene c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene. 3:1988;17-22.
125. Rao G. N., Berk B. C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70:1992;593-599.
126. Rao G. N., Lassegue B., Griendling K. K., Alexander R. W., Berk B. C. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: Role of protein kinase C. Nucleic Acids Res. 21:1993;1259-1263.
127. Rao G. N., Lassegue B., Griendling K. K., Alexander R. W. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: Role of arachidonic acid. Oncogene. 8:1993;2759-2764.
128. Barchowsky A., Munro S. R., Morana S. J., Vincenti M. P., Treadwell M. Oxidant- sensitive and phosphorylation-dependent activation of NF-κB and AP-1 in endothelial cells. Am. J. Physiol. 269:1995;L829-L836.
129. Büscher M., Rahmsdorf H. J., Litfin M., Karin M., Herrlich P. Activation of the c-fos gene by UV and phorbol ester: Different signal transduction pathways converge to the same enhancer element. Oncogene. 3:1988;301-311.
130. Devary Y., Gottlieb R. A., Lau L. F., Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11:1991;2804-2811.
131. Janssen Y. M. W., Heintz N. H., Mossman B. T. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res. 55:1995;2085-2089.
132. Burton R. H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18:1995;775-794.
133. Baeuerle P. A. The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim. Biophys. Acta. 1072:1991;63-80.
134. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
135. Schreck R., Albermann K., Baeuerle P. A. Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17:1992;221-237.
136. Harrington M. A., Edenberg H. J., Saxman S., Pedigo L. M., Daub R., Broxmeyer H. E. Cloning and characterization of the murine promoter for the colony-stimulating factor-1-encoding gene. Gene. 102:1991;165-170.
137. Shvy Y.-J., Li Y.-J., Kolattukudy P. E. Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem. Biophys. Res. Commun. 169:1990;346-351.
138. Collins T., Williams A., Johnson G. I., Kim J., Eddy R., Shows T., Gimbrone M. A. Jr., Bevilacqua M. P. Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J. Biol. Chem. 266:1991;2466-2473.
139. Parhami F., Fang Z. T., Fogelman A. M., Andalibi A., Territo M. C., Berliner J. A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92:1993;471-478.
140. Rajavashisth T. B., Andalibi A., Territo M. C., Berliner J. A., Navab M., Fogelman A. M., Lusis A. J. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 344:1990;254-257.
141. Cushing S. D., Berliner J. A., Valente A. J., Terito M. C., Navab M., Parhami F., Gerrity R., Schwartz C. J., Fogelman A. M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:1990;5134-5138.
142. Liao F., Andalibi A., deBeer F. C., Fogelman A. M., Lusis A. J. Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91:1993;2572-2579.
143. Yan S. D., Schmidt A. M., Anderson G. M., Zhang J., Brett J., Zou Y. S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:1994;9889-9897.
144. Lo S. K., Janakidevi K., Lai L., Malik A. B. Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am. J. Physiol. 264:1993;L406-L412.
145. Shibanuma M., Kuroki T., Nose K. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene. 5:1990;1025-1032.
146. Satriano J. A., Shuldiner M., Hora K., Xing Y., Shan Z., Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor- α and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J. Clin. Invest. 92:1993;1564-1571.
147. Matthews N., Neale M. L., Jackson S. K., Stark J. M. Tumour cell killing by tumour necrosis factor: Inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology. 62:1987;153-155.
148. Staal F. J. T., Roederer M., Herzenberg L. A., Herzenberg L. A. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 87:1990;9943-9947.
149. Garrett R. I., Boyce B. F., Oreffo R. O. C., Bonewald L., Poser J., Mundy G. R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85:1990;632-639.
150. Ohba M., Shibanuma M., Kuroki T., Nose K. Production of hydrogen peroxide by transforming growth factor- β 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell Biol. 126:1994;1079-1088.
151. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
152. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin. Invest. 89:1992;1006-1013.
153. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74:1994;1141-1148.
154. Yamauchi N., Kuriyama H., Watanabe N., Neda H., Maeda M., Niitsu Y. Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res. 49:1989;1671-1675.
155. Zimmerman R. J., Marafino B. J. Jr., Chan A., Landre P., Winkelhake J. L. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. J. Immunol. 142:1989;1405-1409.
156. Zimmerman R. J., Chan A., Leadon S. A. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res. 49:1989;1644-1648.
157. Meier B., Radeke H. H., Selle S., Younes M., Sies H., Resch K., Habermehl G. G. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor- α Biochem. J. 263:1989;539-545.
158. Matsubara T., Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J. Immunol. 137:1986;3295-3298.
159. Schreck R., Meier B., Männel D. N., Dröge W., Baeuerle P. A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1992;1181-1194.
160. Suzuki Y. J., Aggarwal B. B., Packer L. α -Lipoic acid is a potent inhibitor of NF-κB activation in human T cells. Biochem. Biophys. Res. Commun. 189:1992;1709-1715.
161. Suzuki Y. J., Packer L. Inhibition of NF-κB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277-283.
162. Suzuki Y. J., Mizuno M., Packer L. Signal transduction for NF-κB activation: Proposed location of antioxidant-inhibitable step. J. Immunol. 153:1994;5008-5015.
163. Staal F. J. T., Roederer M., Raju P. A., Anderson M. T., Ela S. W., Herzenberg L. A., Herzenberg L. A. Antioxidants inhibit stimulation of HIV long terminal repeat-directed transcription. AIDS Res. Human Retroviruses. 9:1993;299-306.
164. Faruqi R., de la Motte C., DiCorleto P. E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94:1994;592-600.
165. Marui N., Offermann M. K., Swerlick R., Kunsch C., Rosen C. A., Ahmad M., Alexander R. W., Medford R. M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1993;1866-1874.
166. Schmidt K. N., Amstad P., Cerutti P., Baeuerle P. A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chemistry and Biology. 2:1995;13-22.
167. Suzuki Y. J., Packer L. Inhibition of NF-κB DNA binding activity by α -tocopheryl succinate. Biochem. Mol. Biol. Int. 31:1993;693-700.
168. Israël N., Cougerot-Pocidalo M.-A., Aillet F., Virelizier J.-L. Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149:1992;3386-3393.
169. Brennan P., O'Neill L. A. J. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta. 1260:1995;167-175.
170. Anderson M. T., Staal F. J. T., Gitler C., Herzenberg L. A., Herzenberg L. A. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;11527-11531.
171. Suzuki Y. J., Mizuno M., Packer L. Transient overexpression of catalase does not inhibit TNF- or PMA-induced NF-κB activation. Biochem. Biophys. Res. Commun. 210:1995;537-541.
172. Hockenbery D. M., Oltvai Z. N., Yin X.-M., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
173. Rothstein J. D., Bristol L. A., Hosler B., Brown R. H. Jr, Kuncl R. W. chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA. 91:1994;4155-4159.
174. Troy C. M., Shelanski M. L. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc. Natl. Acad. Sci. USA. 91:1994;6384-6387.
175. Malorni W., Rivabene R., Santini M. T., Donelli G. N-Acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett. 327:1993;75-78.
176. Sandstrom P. A., Roberts B., Folks T. M., Buttke T. M. HIV gene expression enhances T cell susceptibility of hydrogen peroxide-induced apoptosis. AIDS Res. Human Retroviruses. 9:1993;1107-1113.
177. Sandstrom P. A., Mannie M. D., Buttke T. M. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: Oxidative stress as a mediator of apoptosis. J. Leukoc. Biol. 55:1994;221-226.
178. Abello P. A., Fidler S. A., Bulkley G. B., Buchman T. G. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch. Surg. 129:1994;134-140.
179. Albrecht H., Tschopp J., Jongeneel C. V. Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-κB by TNF. FEBS Lett. 351:1994;45-48.
180. Tishler R. B., Calderwood S. K., Coleman C. N., Price B. D. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53:1993;2212-2216.
181. Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymoyctes. Nature. 362:1993;847-849.
182. Suda N., Morita I., Kuroda T., Murota S. Participation of oxidative stress in the process of osteoclast differentiation. Biochim. Biophys. Acta. 1157:1993;318-323.
183. Bax B. E., Alam A. S. M. T., Banerji B., Bax C. M. R., Bevis P. J. R., Stevens C. R., Moonga B. S., Blake D. R., Zaidi K. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem. Biophys. Res. Commun. 183:1992;1153-1158.
184. Steinbeck M. J., Appel W. H. Jr, Verhoeven A. J., Karnovsky M. J. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J. Cell Biol. 126:1994;765-772.